GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
V

Vicore Pharma Holding VICO.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

10.82

+5.87%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

13 analysts, 1 Feb 2026. The analysts' own views, not ours.

  • 4Strong buy
  • 8Buy
  • 1Hold
  • 0Sell
  • 0Strong sell

Price targets

Brokers' own targets, 1 Feb 2026. Not our view.

Last close 10.82Average target 26.18

Low
15.15
Average
26.18
Median
26.01
High
42.00

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028FY2029FY2030
RevenueSEK 2.9mSEK 25.4mSEK 3.7mSEK 2.3mSEK 4.7m
Revenue, highestSEK 2.9mSEK 25.4mSEK 3.7mSEK 2.3mSEK 4.7m
Revenue, lowestSEK 2.9mSEK 25.4mSEK 3.7mSEK 2.3mSEK 4.7m
Earnings per share-1.85-1.58-1.93-2.37-2.86
Earnings per share, highest-1.43-0.79-1.38-2.37-2.86
Earnings per share, lowest-2.03-2.23-2.74-2.37-2.86
Analysts88522

Earnings against forecasts

Earnings per share by fiscal quarter

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q4 2023
Forecast-0.40-0.48-0.46-0.47-0.46-0.44-0.37-0.59
Reported-0.50-0.39-0.54-0.48-0.49-0.44-0.40-0.97
Difference-24.4%+18.8%-18.7%-2.3%-6.5%0.0%-8.9%-66.2%

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

3 / 10

Revenue growth 62.5% a year over 10 years. Return on equity -14.9%.

Model fair value

10.52

From earnings —, from revenue 10.52.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.